Financial News

Spyre (SYRE) Climbs 42% as Treatment Candidate Poses ‘Best-in-Class’ Potential

MichaelMichael
Apr 21, 2026 - 05:00
 0  0
Spyre (SYRE) Climbs 42% as Treatment Candidate Poses ‘Best-in-Class’ Potential
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
Michael
Michael Veteran Owned and Operated Business

Related Posts

Avis Budget (CAR) Soars 65% — Here’s Why

Avis Budget (CAR) Soars 65% — Here’s Why

Michael Apr 21, 2026  0  0

Hims & Hers (HIMS) Jumps 48% Ahead of Earnings

Hims & Hers (HIMS) Jumps 48% Ahead of Earnings

Michael Apr 21, 2026  0  0

Major crypto platform shuts down amid market slump

Major crypto platform shuts down amid market slump

Michael Apr 21, 2026  0  0

Jim Cramer Discusses Alaska Air as a Potential Acquisition Target

Jim Cramer Discusses Alaska Air as a Potential Acquisit...

Michael Apr 21, 2026  0  0

National Australia Bank flags $503 million impairment hit on Mideast volatility

National Australia Bank flags $503 million impairment h...

Michael Apr 21, 2026  0  0

EQT Declares Quarterly Dividend of $0.165 per Share

EQT Declares Quarterly Dividend of $0.165 per Share

Michael Apr 21, 2026  0  0